PBPK-Model Biodistribution of Gold and Silver Nanoparticles in the Body of Laboratory Animals and Humans at Different Ways of Income

Abstract:

For needs of the modern science, prediction of nanoparticles (NPs) biodistribution is necessary to avoid the disastrous consequences of its uncontrolled usage. For these purposes we have created the mathematical model of NPs’ biokinetics which can predict how much NPs would be in different organs in laboratory animals’ or human’s organism after different ways and regimes of injections. It is based on PBPK-modelling conception where the blood is the main transport of NPs and organs or tissues are proposed as compartment of NPs’ accumulation. The extrapolation from experimental data for laboratory animals to the human organism is implemented by the method of biological similarity. The special algorithm has been created to find the biokinetic constants, which allows to recreate experimental data, and it is based on the method of successive approximation by the criterion of maximum plausibility.The model is released as a computer code on the MATLAB language. There are evaluations of the model’s parameters for two experiments: for single intragastric injection in rat solutions with 35 nm silver NPs and with 8 nm gold NPs. The result of calculations is represented as graph for some organs (liver, kidney and spleen) and it could be considered as acceptable in recreation experimental data. There is also results of calculation for human organism that are got from biokinetic constants by the mechanism of extrapolation. The proposed model can be adapted for others types of metal NPs.

• Periodical: Nano Hybrids and Composites (Volume 13)
• Pages: 301-305
• DOI: https://doi.org/10.4028/www.scientific.net/NHC.13.301
• Online since: January 2017
• Authors: Ekaterina S. Kormazeva, Vladimir Yu. Soloviev*
• Keywords: Biokinetics, Gold Nanoparticles, Human, PBPK-Models, Rats, Silver Nanoparticles

References

[1] N. Khlebtsov, V. Bogatyrev, L. Dyckman, et al., Analytic and theranostic applications of gold nanoparticles and multifunctional nanocomposites, Theranostic 3-3 (2013).

[2] L. Sintubin, W. Verstraete, N. Boon, Biologically produced nanosilver: Current state and future perspectives, Biotechnol Bioeng, 2012, 109: 24222-24236.

DOI: 10.1002/bit.24570

[3] I. Nestorov, Whole body pharmacokinetic models, Clin Pharmacokinet 42 -10 (2003); pp.883-904.

[4] H. J. Clewell, Physiologically based pharmacokinetic modeling, Preclinical Development Handbook: ADME and Biopharmaceutical Properties, John Wiley & Sons, Inc, 2008, pp.1167-1221.

DOI: 10.1002/9780470249031.ch35

[5] Li. Mingguang, Khuloud T. Al-Jamal, K. Kostarelos, et al., Physiologically based pharmacokinetic modeling of nanoparticles, American Chemical Society 4-11 (2010).

[6] G. Bacher, N. von Goetz, K. Hunderbuhler, A physiologically based pharmacokinetic model for ionic and silver nanoparticles, Int. J. of Nanomedicine 8 (2013), pp.3365-3382.

DOI: 10.2147/ijn.s46624

[7] M.L. Shelley, R.L. Harris, B.A. Boehlecke, A mathematical model of bronchial absorption of vapors in the human lung and its significance in pharmacokinetic modeling, SAR QSAR Environ res. (1996).

DOI: 10.1080/10629369608031714

[8] L. MacCalman, C. L. Tran, E. Kuempel, Development of a Bio-Mathematical Model in Rats to Describe Clearance, Retention and Translocation of Inhaled Nano Particles throughout the Body. J. Phys.: Conf. Ser. 2009, 151, 012028.

DOI: 10.1088/1742-6596/151/1/012028

[9] I.V. Gmoshinski, S.A. Khotimchenko, V.O. Popov et al. Nanomaterials and Nanotechnologies: analysis and control methods / Russian Chemical. 2013. Vol. 82, No 1. pp.48-76.

DOI: 10.1070/rc2013v082n01abeh004329